Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects

NCT00204893 ↗

Phase 1 Completed 12 enrolled University of Wisconsin, Madison Nephro-Tech 1, LLC · collab

NaSingle-groupOpen-labelPrevention

Summary

This is a Phase I, single center, open-label study of the dietary supplement calcium formate in normal, healthy female subjects. The purpose of the study is to determine whether daily use of calcium formate is safe and whether it accumulates in the eye.

Timeline

Start: 2003-07
Primary completion: 2007-03
Completion: 2007-03

Publications

Results Altaweel MM, Hanzlik RP, Ver Hoeve JN, Eells J, Zhang B. Ocular and systemic safety evaluation of calcium formate as a dietary supplement. J Ocul Pharmacol Ther. 2009 Jun;25(3):223-30. doi: 10.1089/jop.2008.0128.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Calcium Formate	Unknown	3900 mg	Oral

Indications

No indication recorded.